相关产品推荐更多 >

Tralokinumab (anti-IL-13),1044515-88-9,ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot,阿拉丁
¥1099.90
Avdoralimab (anti-C5AR1),2226393-85-5,ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot,阿拉丁
¥669.90
HS271,2410393-15-4,≥99%,阿拉丁
¥3500.90
T6167923,2437475-16-4,10mM in DMSO,阿拉丁
¥5647.90
Bevacizumab (anti-VEGF),216974-75-3,ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot,阿拉丁
¥209.90
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 询价记录
- 文献和实验
- 技术资料
- 保存条件:
-80℃储存;避免反复冻融
- 英文名:
Zolbetuximab (anti-CLDN18.2)
- 库存:
现货
- 供应商:
上海阿拉丁生化科技股份有限公司
- CAS号:
1496553-00-4
- 规格:
Ab170589-5mg/Ab170589-1mg/Ab170589-10mg/Ab170589-100μg
| 规格: | Ab170589-5mg | 产品价格: | ¥6759.9 |
|---|---|---|---|
| 规格: | Ab170589-1mg | 产品价格: | ¥2739.9 |
| 规格: | Ab170589-10mg | 产品价格: | ¥10799.9 |
| 规格: | Ab170589-100μg | 产品价格: | ¥549.9 |
Zolbetuximab 是一种靶向 Claudin-18.2 的单克隆抗体。Zolbetuximab 通过免疫效应机制介导对 Claudin-18.2 阳性细胞的特异性杀伤。Zolbetuximab 可用于胃肠道腺癌和胰腺肿瘤的研究。
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
- 作者
- 内容
- 询问日期
文献和实验In situ hybridisation to alpha satellite sequences (chromosome specific)
. After 2 days fixation the slides are rinsed in H2 O and allowed to air dry. Store dry, dust-free. Paraffin sections. Take 6m m sections onto APES treated slides (see below) and bake overnight at 60C. Dewax in Xylene, 2 x 5 minutes. Then immerse as follows
终浓度为0.2M),65oC处理3h解交联,跑电泳,检测超声破碎的效果。 9、在100ul的超声破碎产物中,加入900ulChIPDilutionBuffer和20ul的50×PIC。 再各加入60ulProteinAAgarose/SalmonSpermDNA。4oC颠转混匀1h。 10、1h后,在4摄氏度静置10min沉淀,700rpm离心1min。 11、取上清。各留取20ul做为input。一管中加入1ul抗体,另一管中则不加抗体。4oC颠转
, and additives were hydrogen-free or deuterated. Samples could be dissolved in as little as 10 µL, but typically, spectrometers were designed for sample volumes of at least 500 µL. Due to the inherently low sensitivity, concentrations of peptides ranged
技术资料暂无技术资料 索取技术资料






